Vijay Pande, a general partner at Andreessen Horowitz, runs the firm's bio fund. So far, the fund's made investments in companies including Freenome, which is developing a blood test that screens for the earliest signs of cancer, <a href="https://q.bio/">and Q</a>, a startup that wants to quantify the human physiology.